Scientific Justification of A Personalized Approach To The Management of Patients with Terminal Renal Failure

Authors

  • Otynshiyeva Shynar Abdigapparkyzy Doctor-therapis, PhD student of the Department of Propaedeutics of internal diseases South Kazakhstan medical academy, Shymkent, Kazakhstan,
  • Narmanova Oryngul Zhaksybayevna Professor of the department of public health NPJSC “ASTANA MEDICAL UNIVERSITY” Doctor of medicine, nephrologist
  • Assel Sadykova PhD, Post Doc, Ass. Professor, Al-Farabi Kazakh National University
  • Karlygash Tazhibayeva PhD, PostDoc, MD, Ass.Professor, Al-Farabi Kazakh National University, Al-Farabi Kazakh National University, Asfendiyarov Kazakh National Medical University, Oncologistgynecologist of Almaty Regional Multidisciplinary Clinic
  • Abenova Moldir Doctor-Pediatric, Master of Medical Sciences Chief Specialist of the Department for the Development of the Formulary System and Professional Expertise of Medicines and Medical Devices Department for Improving the Medicines Policy of the RSE at the REM “National Scientific Research Center for Healthcare named after Salidat Kairbekova” of the Ministry of Health of the Republic of Kazakhstan Kazakhstan, Astana
  • Kemelbekov Kanatzhan MD., PhD, Associate Professor Head of the Department of Pediatrics-1, South Kazakhstan medical academy,Shymkent, Kazakhstan
  • Baimakhanova Bakhtygul ssociate Professor South Kazakhstan medical academy, Department of Pediatrics- 1,Shymkent, Kazakhstan
  • Akzhol Darhan Assistante of the Department of Propaedeutics of internal diseases South Kazakhstan medical academy,Shymkent, Kazakhstan
  • Bekmurzaeva Elmira Doctor of Medical Sciences, Professor, Department of Propaedeutics of internal diseases South Kazakhstan medical academy,Shymkent, Kazakhstan

DOI:

https://doi.org/10.3329/bjms.v23i3.75119

Keywords:

personalized approach, end stage, innovation, hemodialysis, peritoneal dialysis, transplantation.

Abstract

Currently, there is uncertainty about the ideal treatment for recovery and a personalized approach to the management of patients with terminal renal failure.Therefore, a systematic review was conducted over the past 10 years.Network meta-analysis of randomized control trials (RCTS), which compared the prevalence of chronic renal failure (CRF), according to various literature data. AccordingtoWHOitisfrom 50 to 250 peopleper 1 millionpopulationperyear.Active therapy for terminal CRF (hemodialysis, peritoneal dialysis, kidney transplantation) is received in Western Europe by 500-600 patients, in the USA and Japan - 1000-1200 patients, while in Kazakhstan-about 100 patients per 1 million population per year. The ten-year probability of survival of patients with terminal CRF in active therapy exceeds 50%, excluding patients with diabetes mellitus.Arterial hypertension remains the most frequent symptom, largely determining the prognosis of patients with CRF. Ten-year survival of patients with CRF in combination with hypertension in hemodialysis is lower than in normotensive patients by 30-50%. Successfully performed a kidney transplant can eliminate the symptoms of chronic renal failure.

Bangladesh Journal of Medical Science Vol. 23 No. 03 July’24 Page : 851-863

Downloads

Download data is not yet available.
Abstract
208
PDF
326

Downloads

Published

2024-07-29

How to Cite

Abdigapparkyzy, O. S., Zhaksybayevna, N. O., Sadykova, A., Tazhibayeva, K., Moldir, A., Kanatzhan, K., Bakhtygul, B., Darhan, A., & Elmira, B. (2024). Scientific Justification of A Personalized Approach To The Management of Patients with Terminal Renal Failure. Bangladesh Journal of Medical Science, 23(3), 851–863. https://doi.org/10.3329/bjms.v23i3.75119

Issue

Vol. 23 No. 3 (2024)

Section

Original Articles

License

Copyright (c) 2024 Otynshiyeva Shynar Abdigapparkyzy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.